Interpreting Cognivue® One-Page Test Results

6-17-16 HQ test report with descriptions


Clinical Testing Context

For more information, please review the Cognitive care flow chart for clinical use. For a laminated copy of the flow chart, Contact Us

Three factors provide important context for evaluating Cognivue scores. All test scores should be considered in the context of:

  1. Clinical correlation with the patient’s medical conditions and medical history.
  1. Previous Cognivue test results, or related testing that may indicate the level of baseline function.
  1. New diagnoses that might explain declines in function and aid in planning for further diagnostic testing.

Discussing Test Results with Patients

Cognivue testing provides an adjunctive tool for assessing brain functional capacities. Test reports showing good performance, evidence of impairment, and functional decline will require different discussions and follow-up. Refer to page 21 of the Cognivue Practitioner’s Training Manual for discussion recommendations.

Cognivue’s Clinical Use Protocol

  • Candidates are 55 to 95 years of age—with patient, caregiver, or practitioner concerns regarding impairment.
  • Testing is under supervision of a licensed practitioner
    • the staff administers test, and the practitioner interprets the report.
  • Cognivue is an adjunctive test, so clinical correlation is required
  • Cognivue is a reimbursable, FDA-approved cognitive test.

Why is it Important to Detect Early Impairment?

  • Treat reversible dementias (specific treatments)
  • Ameliorate irreversible dementias (nootropics and psychotropics)
  • Facilitate contextual care (managing co-morbidities)
  • Support the patient (drive adaptations and manage expectations)
  • Avoid complications (reduce risk of polypharmacy, unnecessary diagnostics, and referrals)
  • Support caregivers (encourage planning and accommodations)

Common, Treatable Causes of Impairment

Common causes of reversible impairment include sleep disorders, infection, systemic illness, and mood disorders.

For more information on types of reversible dementia, please review the Cerebral Assessment Systems White Paper, “Causes of Dementia.”

Metabolic and Systemic Issues Related to Impairment

  • Endocrine disorders: e.g., hypothyroidism
  • Deficiencies: e.g., B vitamins
  • Organ failure: e.g., hepatic, renal, cardiac
  • Inflammatory: e.g., temporal arteritis (GCA)
  • Infectious: e.g., UTIs, URIs, HIV

Assisting Patients with Neurodegenerative Impairment

How Can Primary Care Testing Influence Brain Health Outcomes?

  • Automated, objective multi-domain measures
  • Practitioner interpretation in context of presentation
  • Limit work-up in unimpaired patients
  • Focus work-up in impaired patients
  • Reassure unimpaired patients and their families to limit further work-up and unnecessary referrals
  • Engage impaired patients and caregivers in planning and arranging support services

The Science of Psychophysical Profiles

Top down bottom up processing

See CME 1: “The Origins of Cognivue Technology” for more on the science of psychophysical profiles.


Sample screens for Visuo-Motor Calibration

Sample screens for Visuo-Motor Calibration

The CogniWheel™

CogniWheel from Cerebral Assessment Systems

Contact us today for Continuing Medical Education (CME) presentations.

Learn more about Cognivue, the first FDA-approved device for cognitive testing


Contact us today to learn more about this important breakthrough in cognitive assessment and how you can put it into your practice.